Sublocade Will No Longer Be Available in Australia After December 2026

药物检查

02 7 月 2026

People who are currently on Sublocade may have heard that it will no longer be available in Australia as of 11 December 2026. We know this news is worrying, and many people will have questions about what it means for them and their loved ones.  

What is happening? 

The manufacturer, Indivior, has announced that Sublocade, a long-acting injectable buprenorphine, will be discontinued in Australia. Their decision is based on commercial and operational reasons. It is not because of any new concerns about the medicine’s safety, quality or effectiveness. 

The last planned supply of Sublocade in Australia is 11 December 2026. Existing stock will continue to be available while supplies last, and PBS claims can continue until 31 December 2026. 

What does this mean if you are receiving Sublocade? 

There is still time to plan your ongoing care.  

Speak with your prescribing doctor or clinic, they can work with you to discuss your options and develop a plan that meets your needs.

Will other long-acting injectable buprenorphine medicines still be available? 

Yes. The current announcement only affects Sublocade. 

Buvidal will continue to be available.  

Need someone to talk to? 

We know that changes to opioid dependence treatment can be stressful, and we know this announcement may create uncertainty for many people. Speak with your prescribing doctor or clinic about your options and next steps, and  
if you need further support, your local peer-based Drug User Organisation is here to help. 

州或领地吸毒者组织
澳大利亚首都领地堪培拉危害最小化和倡导联盟(CAHMA): (02) 6253 3643
新南威尔士州NUAA’s Peerline: 1800 644 413
北领地NTAHC: (08) 8944 7777
昆士兰州QuIVAA’s PeerQnect: 1800 175 889
南澳大利亚州SA Harm Reduction Peer Services (SAhrps): 1800 437 222 或者 (08) 83628443
塔斯马尼亚Tasmanian Users and Health Support League (TUHSL): 02 5110 000
维多利亚维多利亚州减少伤害组织 (HRVic)/药物治疗倡导调解服务 (PAMS): 1800 443 844
西澳大利亚州Peer Based Harm Reduction Western Australian (PBHR WA): (08) 9325 8387